{
  "docId": "019de076-b731-71da-a78f-007719e300bb",
  "docSlug": "1616e8b22ac58e7f024f1153201d610f",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 42,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "customer_journey",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "The slide uses a timeline-based journey map to contrast standard treatments with unmet clinical needs.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/13",
  "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
  "deckJsonHref": "/decks/019de076-b731-71da-a78f-007719e300bb.json",
  "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.69,
        "x": 0.055,
        "y": 0.16
      },
      "kind": "diagram",
      "text": "1L, 2L, 3L+ treatment progression",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4141d6da-f49f-44fe-b3ee-7edec9a145b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 1,
        "w": 0.25,
        "x": 0.75,
        "y": 0
      },
      "kind": "image",
      "text": "Illustrative patient image",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "368908c3-05b6-413a-8dab-b92e1cb9a794",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.69,
        "x": 0.055,
        "y": 0.32
      },
      "kind": "list",
      "text": "Standard of Care details for 1L, 2L, and 3L+",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b088a67-b904-4bbb-a89c-5fbb6fefb3b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.69,
        "x": 0.055,
        "y": 0.53
      },
      "kind": "list",
      "text": "Key limitations including resistance mutations, brain penetrance, and adverse events",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aad61558-b65a-462a-805b-dff37ea5e98c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.69,
        "x": 0.055,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Sources: [1] Kwak E. et al., NEJM 2010. [2] Chia P.L. et al., Clin Epidemiol. 2014. [3] Cortellis Sales and Forecasts... [13] Shiba-Ishii et al., Nature Cancer 2022.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7fd3e9d4-78a1-40ea-b482-a8987cd18c64",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.485,
        "x": 0.105,
        "y": 0.085
      },
      "kind": "title",
      "text": "ALK+ NSCLC Patient Journey",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69a7098c-8cb4-44b4-b3bc-f95610dbb275",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "customer-journey-map",
      "slug": null,
      "matchId": "cb5e0a10-c58c-439b-9afa-78b21bbe568a",
      "evidence": "Visualizes the progression of patients through lines of therapy (1L, 2L, 3L+)",
      "confidence": 0.95
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 14,
      "from": 12,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "7d830543-88bb-4201-aa83-945a257879d6",
      "evidence": "The deck presents the patient journey and how Nuvalent's approach addresses their needs.",
      "position": 1,
      "objective": "Show how Nuvalent's approach addresses the needs of patients with ALK+ NSCLC",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.6,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}